Clinical and translational outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease receiving vedolizumab

被引：1
|
作者：
Williamson, K. D. [1 ,2 ]
Slevin, S. [1 ]
Willberg, C. [2 ]
Chapman, R. [1 ]
Klenerman, P. [1 ,2 ]
Keshav, S. [1 ]
机构：
[1] Univ Oxford, Translat Gastroenterol Unit, Oxford, England
[2] Univ Oxford, Peter Medawar Inst Pathogen Res, Oxford, England
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31496-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-370
引用
下载
收藏
页码：S544 / S545
页数：2
相关论文
共 50 条
  • [31] Prevalence and Phenotype of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis
    Huynh, Dep
    Bate, John P.
    Andrews, Jane M.
    Johnson, Richard
    LeMire, Marc
    Nind, Garry
    Harley, Hugh A.
    GASTROENTEROLOGY, 2012, 142 (05) : S991 - S991
  • [32] COLECTOMY IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS
    POST, AB
    BOZDECH, JM
    LAVERY, I
    BARNES, DS
    DISEASES OF THE COLON & RECTUM, 1994, 37 (02) : 175 - 178
  • [33] Survival outcomes of primary sclerosing cholangitis patients with inflammatory bowel disease after liver transplantation
    Peverelle, M.
    Paleri, S.
    Hughes, J.
    Testro, A.
    Angus, P.
    De Cruz, P.
    Gow, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 64 - 65
  • [34] Colorectal cancer in patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
    Lopez-Panqueva, R. D. P.
    Ortiz-Pereira, M.
    Park Noh, J. H.
    Castillo, C.
    Mendoza de Molano, B.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S97 - S97
  • [35] Inflammatory bowel disease course in patients transplanted for primary sclerosing cholangitis
    Wallack, Ariana
    Levine, Joel S.
    Forman, Lisa
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 287 - 288
  • [36] Primary Sclerosing Cholangitis and Distribution of Inflammatory Bowel Disease
    Feurer, Matthew E.
    Hilden, Kristen
    Adler, Douglas G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (12) : 1418 - 1418
  • [37] Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review
    Da Cunha, Teresa
    Vaziri, Haleh
    Wu, George Y.
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (03) : 531 - 542
  • [38] Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAID
    Caron, B.
    Peyrin-Biroulet, L.
    Nachury, M.
    Bouhnik, Y.
    Seksik, P.
    Bouguen, G.
    Caillo, L.
    Laharie, D.
    Carbonnel, F.
    Altwegg, R.
    Reenaers, C.
    Serrero, M.
    Boureille, A.
    Nancey, S.
    Filippi, J.
    Abitbol, V.
    Savoye, G.
    Vuitton, L.
    Viennot, S.
    Fumery, M.
    Reymond, M.
    Bronowicki, J. P.
    Reimund, J. -M.
    Amiot, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S278 - S278
  • [39] EFFECT OF VEDOLIZUMAB, INFLIXIMAB, AND ADALIMUMAB ON BILIARY INFLAMMATION IN INDIVIDUALS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE
    Tse, Chung Sang
    Raffals, Laura H.
    Loftus, Edward V.
    Gossard, Andrea
    Lightner, Amy L.
    GASTROENTEROLOGY, 2018, 154 (06) : S302 - S303
  • [40] EFFICACY OF VEDOLIZUMAB IN REDUCING BILIARY INFLAMMATION IN PRIMARY SCLEROSING CHOLANGITIS (PSC) IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
    Tse, Chung Sang
    Loftus, Edward V.
    Raffals, Laura H.
    Gossard, Andrea
    Lightner, Amy L.
    GASTROENTEROLOGY, 2017, 152 (05) : S402 - S403
12345